HSIC vs IDYA · P/E 24, rev $6.83B vs rev $15.4M
Henry Schein Inc (HSIC) versus Ideaya Biosciences Inc (IDYA) — a side-by-side from cached financials, not a winner call.
Henry Schein Inc (HSIC) is a medical distribution company listed on NASDAQ.
Ideaya Biosciences Inc (IDYA) is a biotechnology company listed on NASDAQ.
Latest reported HSIC revenue for 2026-06-27 was $6.83B. Net income was $201.0M. HSIC currently screens at market cap $9.11B and trailing P/E 24.2.
Latest reported IDYA revenue for 2026-06-30 was $15.4M. Net income was -$211.0M. IDYA currently screens at market cap $2.96B.
HSIC currently screens at market cap $9.11B and trailing P/E 24.2. IDYA currently screens at market cap $2.96B.
Not investment advice. Open the HSIC and IDYA stock pages for the full models.
Not investment advice.